Apellis Pharmaceuticals buy BiotechBee
Start price
17.09.23
/
60%
€41.00
Target price
30.09.25
€60.00
Performance (%)
-20.73%
End price
14.12.24
€32.50
Summary
This prediction ended on 14.12.24 with a price of €32.50. The prediction for Apellis Pharmaceuticals disappointed with a performance of -20.73%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% |
According to BiotechBee what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Buy mit Kursziel 60,0
In the thread Trading Apellis Pharmaceuticals
Stopped prediction by BiotechBee for Apellis Pharmaceuticals
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€37.00
30.07.23
30.07.23
€50.00
31.01.26
31.01.26
10.81%
17.09.23
17.09.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€50.50
17.07.23
17.07.23
€90.00
31.03.26
31.03.26
18.81%
17.07.23
17.07.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€69.48
29.09.22
29.09.22
€80.00
31.12.24
31.12.24
17.30%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€64.19
07.09.22
07.09.22
€35.00
31.12.24
31.12.24
8.24%
29.09.22
29.09.22
Could be very worthwhile Investment >20% year